Soliton Files 510(k) with FDA for RAP Device for the Reduction of Cellulite

Soliton Inc announces that it filed for 510(k) premarket clearance with the US Food and Drug Administration for its second generation Rapid Acoustic Pulse (RAP) device for the reduction in the appearance of cellulite.